Search research articles
Contact Us
Filters
Showing results (41-50 of 232) with videos related to
Page
of 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib
Kostandinos Sideras, Michael E Menefee, Jill K Burton, et al.
Leukemia & Lymphoma
|
July 16, 2005
The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group
Douglas P Olson, Barbara J Taylor, Mei La, et al.
Cancer Letters
|
February 2, 2024
Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patients
Morgan A Butrovich, Jiyue Qin, Xiaonan Xue, et al.
Breast Cancer Research and Treatment
|
November 16, 2011
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer
Elaina M Gartner, Paula Silverman, Michael Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Design issues of randomized phase II trials and a proposal for phase II screening trials
Lawrence V Rubinstein, Edward L Korn, Boris Freidlin, et al.
Heart Failure Clinics
|
July 14, 2011
The importance of clinical grading of heart failure and other cardiac toxicities during chemotherapy: updating the common terminology criteria for clinical trial reporting
Akm Hossain, Alice Chen, Percy Ivy, et al.
Journal of Biopharmaceutical Statistics
|
April 23, 2009
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experience
Elisabeth I Heath, Patricia M LoRusso, S Percy Ivy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2012
Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer
Anita Schwandt, Tarek Mekhail, Balazs Halmos, et al.
Cancer Chemotherapy and Pharmacology
|
May 20, 2026
Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigation
Heekyung Lee, Allison Dunn, Sarah E Taylor, et al.
Cancer Chemotherapy and Pharmacology
|
May 5, 2010
Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients
Jill Kolesar, Richard C Brundage, Marcia Pomplun, et al.
Page
of 24
Search research articles
Search
Showing results (41-50 of 232) with videos related to
Sort By:
Page
of 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2010
Profound hair and skin hypopigmentation in an African American woman treated with the multi-targeted tyrosine kinase inhibitor pazopanib
Kostandinos Sideras, Michael E Menefee, Jill K Burton, et al.
Leukemia & Lymphoma
|
July 16, 2005
The prognostic significance of P-glycoprotein, multidrug resistance-related protein 1 and lung resistance protein in pediatric acute lymphoblastic leukemia: a retrospective study of 295 newly diagnosed patients by the Children's Oncology Group
Douglas P Olson, Barbara J Taylor, Mei La, et al.
Cancer Letters
|
February 2, 2024
Impact of the 2021 CKD-EPI equation on anticancer pharmacotherapy in black and non-black cancer patients
Morgan A Butrovich, Jiyue Qin, Xiaonan Xue, et al.
Breast Cancer Research and Treatment
|
November 16, 2011
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer
Elaina M Gartner, Paula Silverman, Michael Simon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 30, 2005
Design issues of randomized phase II trials and a proposal for phase II screening trials
Lawrence V Rubinstein, Edward L Korn, Boris Freidlin, et al.
Heart Failure Clinics
|
July 14, 2011
The importance of clinical grading of heart failure and other cardiac toxicities during chemotherapy: updating the common terminology criteria for clinical trial reporting
Akm Hossain, Alice Chen, Percy Ivy, et al.
Journal of Biopharmaceutical Statistics
|
April 23, 2009
Theoretical and practical application of traditional and accelerated titration Phase I clinical trial designs: the Wayne State University experience
Elisabeth I Heath, Patricia M LoRusso, S Percy Ivy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 20, 2012
Phase-II trial of rebeccamycin analog, a dual topoisomerase-I and -II inhibitor, in relapsed "sensitive" small cell lung cancer
Anita Schwandt, Tarek Mekhail, Balazs Halmos, et al.
Cancer Chemotherapy and Pharmacology
|
May 20, 2026
Enhancing triapine treatment: strategies for dose optimization and methemoglobin level mitigation
Heekyung Lee, Allison Dunn, Sarah E Taylor, et al.
Cancer Chemotherapy and Pharmacology
|
May 5, 2010
Population pharmacokinetics of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (Triapine®) in cancer patients
Jill Kolesar, Richard C Brundage, Marcia Pomplun, et al.
Page
of 24